Dr. Amouzegar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2022 - 2025
UPMC Medical EducationResidency, Internal Medicine, 2019 - 2022
Harvard Medical SchoolPost-Doctoral Fellowship, 2015 - 2019
Tehran University of Medical Sciences School of MedicineClass of 2014
Certifications & Licensure
TX State Medical License 2023 - 2026
PA State Medical License 2019 - 2022- American Board of Internal Medicine Internal Medicine
- ECFMGECFMG certification
Publications & Presentations
PubMed
- 3 citationsNext-Generation Immunotherapy Approaches in MelanomaTyler Buchanan, Afsaneh Amouzegar, Jason J. Luke
Current Oncology Reports. 2021-08-03 - 178 citationsSTING Agonists as Cancer Therapeutics.Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N. Filderman, Walter J. Storkus, Jason J. Luke
Cancers. 2021-05-30 - 24 citationsNeurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell ActivationMan Yu, Sang-Mok Lee, Hyun Soo Lee, Afsaneh Amouzegar, Takeshi Nakao
The American Journal of Pathology. 2020-01-01
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
